Remdesivir To Be Used In Patients With Moderate To Severe Covid: Centre
NDTV
The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines.
The Centre on Friday said Remdesivir drug should only be used in patients with 'moderate to severe' COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom.
It also warned against use of the drug in patients who are not on oxygen support or in-home settings.
According to the clinical guidance issued by the Union health ministry for management of the infection in adult patients, Remdesivir has been asked to be "used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom".
The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines.